Today Yoga guru Ramdev launched a new Ayurved medicine by Patanjali that can cure Covid19 in just 7 days. But there is no proof yet to confirm the usages and sucess rate of the drug.
The medicines, “Coronil and Swasari”, were developed based on research and trials on 280 patients across the country, Patanjali’s founder Ramdev told the media. The medicines come in a Corona kit priced at Rs 545, which was to be sold across India within a week. The Ministry of Ayush has asked Patanjali to provide at the earliest details like the composition of the medicines, the results of its research, the hospitals where the research was conducted, whether the company had a clearance from the Institutional Ethics Committee and whether it had registered for the clinical trials.
There is no scientific evidence of any alternative cure for COVID-19, even as vaccines are being tested by many countries. The World Health Organisation has also cautioned against such claims.
“Facts of the claim and details of the stated scientific study are not known to the ministry,” the Ayush Ministry said in a statement hours after the Patanjali launch. The ministry has also asked for copies of the license and product approval details of the Ayurvedic medicines, which were made in Haridwar, Uttarakhand.
“The whole country and the world were waiting for medicine or vaccine for corona. We are proud to announce that the first Ayurvedic, clinically controlled trial-based evidence and research-based medicine has been prepared by the combined efforts of Patanjali Research Centre and NIMS,” Ramdev stated while talking to News agency ANI.
Ramdev also claimed Patanjali’s medicines showed “100 per cent favorable results” in clinical trials.
“We are launching COVID medicines Coronil and Swasari today. We conducted two trials of these, first clinical controlled study, which took place in Delhi, Ahmedabad, among many other cities. Under this 280 patients were included and 100 percent of those recovered. We were able to control Corona and its complications in this. After this the all-important clinical control trial was conducted,” he said.
Patanjali collaborated with the privately-owned National Institute of Medical Sciences or NIMS University, Jaipur.